News Image

Minerva Neurosciences Reports First Quarter 2025 Financial Results and Business Updates

Provided By GlobeNewswire

Last update: May 13, 2025

BURLINGTON, Mass., May 13, 2025 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, today reported business updates and financial results for the first quarter of 2025 ended on March 31, 2025.   

Read more at globenewswire.com

MINERVA NEUROSCIENCES INC

NASDAQ:NERV (8/4/2025, 11:53:02 AM)

1.94

+0.03 (+1.57%)



Find more stocks in the Stock Screener

Follow ChartMill for more